Unfunded promises as the UK health debate takes centre stage.
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D006291:Health Policy / Q000191:economics*; D006297:Health Services Accessibility / Q000191:economics / Q000592:standards*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics; D011057:Politics; D006113:United Kingdom
D000970:Antineoplastic Agents